A Career in Science Management

Posted by on February 13th, 2012


Last June, Eva summarised the Node’s alternative careers stories, personal accounts of how scientists made their transitions from research into various alternative career paths. As a friend of Andrea Hutterer, who is now the Fellowships Manager at EMBO, I witnessed her exciting leap from the bench into science management back in 2010, and now asked her to tell her story. I’m sure her experiences will interest the Node’s readers and complement the alternative careers stories already available on the site. Enjoy the interview!

 

Briefly tell us about your scientific career.

I studied biochemistry in Vienna and then did both my diploma thesis and my PhD in Jürgen Knoblich’s lab at IMP and IMBA in Vienna. The focus of my thesis was asymmetric cell division in the nervous system of Drosophila. After that I joined Masanori Mishima’s group at the Gurdon Institute in Cambridge, UK, for a postdoc. In his lab, I studied the process of cytokinesis.

Why did you quit research?

I was simply not sufficiently fascinated by one particular biological problem. My CV was good in scientific terms, so I think I could have gone ahead and started to apply for PI positions. But without being passionate about a question I think it’s hard to be successful, and being quite ambitious I decided it’s not the right career path for me.

What got you interested in research funding and policy? Did you consider other career paths?

Once I had decided to look into alternative careers, I needed to find out which career paths were open to me. I looked into loads of things - management consulting, scientific editing, medical writing, conference organising and science communication. In the end it was clear that science management was the best choice for me, as I would still have direct contact to scientists and thereby get a broad overview of scientific progress and emerging fields. On top of that, one can make a difference in terms of policy, for example by dealing with researchers’ employment conditions or gender issues.

Did you take any additional courses to polish your CV?

At the Gurdon Institute I was lucky enough to be able to take advantage of the fantastic careers service Cambridge University offers. In the beginning, I almost randomly took courses such as microeconomics, web-authoring and programming languages. This helped in a way that I found out quickly that pure economics were not entirely my thing and Pearl was not my language. Other courses were more useful, for example when I learned the basics of using HTML to build websites or how to best write a CV for non-scientific jobs.

With regard to “polishing” my CV, it wasn’t so much the courses I listed but more how I organised the CV. I tried to emphasise my soft skills and highlighted extracurricular activities such as supervising younger students and organising retreats and symposia.

How easy was it to get your first job in funding?

It wasn’t easy at all, not even to get interviews. My scientific CV was good, but I had virtually no other relevant experience. Many employers appreciate even the smallest amount of experience more than a fantastic scientific CV, so what you really need when coming out of a PhD or postdoc is to get a foot in the door.

The first interview I got was with Cancer Research UK, but they didn’t offer me the job. I then got offered a job as Science Manager with the Medical Research Council (MRC) in Swindon, UK. I was quite over-qualified for this job since it didn’t even require a PhD, plus it came with a significant pay cut, but I was glad to have been offered it and accepted. In hindsight, it was the perfect stepping stone.

As preparation for the interviews, the Cambridge Careers Service again proved extremely helpful, because they offered mock interviews with the career advisor. It helped immensely to practise - I found out what I might be asked in an interview and I learned to explore different possibilities for answering these questions. I simply got an idea of what to expect during the process.

What does your work consist of?

On an everyday basis, I do some general administration, the details of which depend on the various fellowship application deadlines: I read proposals, find referees, talk to fellows, talk to my team [Andrea has three administrative staff to manage] and attend in-house management meetings. Every now and then I travel to career events to give talks about the programme, or attend workshops somewhere in Europe, which cover different aspects that come with the programme, such as a recent workshop on tracking research careers.

I also write grant proposals to try to get more money for the programme, and organise and attend the EMBO Fellows’ meetings in Heidelberg and the US. So it’s a very diverse job and I’m never even remotely bored!

Is there anything you miss about working in research?

At the MRC, although my colleagues were great I sometimes missed the international environment, which I do have here at EMBO. Sometimes I also miss standing at the bench, running around in the lab, being physically active. But I’m aware that that would have stopped sooner or later even if I had stayed in research and had become a PI.

What advice do you have for PhD students and postdocs wanting to leave academic research?

Find out why exactly you want to leave and what you would rather do. Even if you’re unclear whether research might be the right thing for you or not, start thinking about alternatives and get involved in non-scientific activities early on. There’s actually quite a lot one can do with our education. You just need to be clear about your goals, have a good non-scientific CV ready and work towards the new career profile. It might take a while until you get the job you have in mind, and you possibly need to be prepared to take pay cuts and will maybe feel slightly under-challenged in your first non-research job, but at least for me it was all worth it.
GD Star Rating
loading…
Share

Tags , ,
Category Careers, Interview | No Comments »

Bio Web Conferences – Critical discussions with developmental biologists for deep learning.

Posted by on February 10th, 2012

Dear Developmental biology community,

I would like to bring to your attention a potentially valuable resource for your teaching and research endeavors.  I am a neurodevelopmental biologist at Smith College.  I started teaching a course in Developmental Biology back in 2005, and since then have been utilizing web conferencing technology to bring the research behind concepts alive in the classroom.  My students have been interacting with leading scientists in the field of developmental biology holding organized Q&A video conferences focused on current and seminal research articles.  I am posting this to the Node as since I started using this pedagogical approach I have been recording these discussions, and with full consent provided, I have established an online repository of these recordings via my lab website.  I have each conference (40 now and growing) organized by topic for ease of searching, and each individual session is further broken down by specific question to facilitate quick access to your greatest interest.

Because these sessions are based on key research papers they are extremely applicable for any teacher or student to use in their own courses as supplemental resources to what is probably the very same topics being covered.  For instance, I often assign my students select conferences to watch to supplement their readings or coverage of the material.  Moreover, in class I will poise certain questions about a topic to my student and after some discussion, click on say, Dr. Cliff Tabin’s response to the similar question.  It provides a new and real perspective to the information that students truly appreciate and fosters long-term retention of the material.

There are also many other positive outcomes to both conducting and watching these conferences.  Namely students gain a very different and revealing perspective of not only where a particular field of Dev Bio is moving, but more personal understandings of who the scientists are and how they got to where they are today.  Listening to these remarkable scientists articulate their thinking process to address the research question is extremely illuminating to the developing scientist in your classroom.

So I invite and encourage you to check out these discussions as I am disseminating them for your benefit and use.  I hope you find them helpful.  Feel free to let me know what you think and, if you like them, how you might use them in your teaching.

“Bio Web Conferences” http://sophia.smith.edu/~mbarresi/lab/biowebconferences.html

Best regards,

Michael J.F. Barresi

P.S. additional post on stem cell documentaries coming….

 
GD Star Rating
loading…
Share

Tags , , , , , , , , ,
Category Education, Interview, Research, Resources, Video | 1 Comment »

Stem cells, cellules souches, Stammzellen: taking research to Europe’s public

Posted by on December 22nd, 2011

It’s been a busy year for EuroStemCell: Europe’s stem cell hub - see www.eurostemcell.org for more information on who we are. We’d like to wish The Node community a happy festive season and a great start to 2012. But before we say goodbye to 2011, we thought you might be interested to know about some of the things we’ve been doing recently…

EuroStemCell goes multilingual


eurostemcell.org is multilingual! Or tri-lingual, at least.

The EuroStemCell website is now available in 2 additional languages, German and French, with Italian and Spanish coming soon. Just click on the flag icons to the right of any page on the website to give the newly translated interface a whirl.

Read more about our translation project, or go straight to the French or German homepage.


Research updates from EU-funded stem cell projects

Our research updates keep you informed about progress in public-funded European stem cell research. Here’s a recent example from our partner, NeuroStemcell.


Using stem cells to develop new therapies for Parkinson’s and Huntington’s diseases


NeuroStemcell brings stem cell biology and clinical science together to develop and test new approaches to stem-cell-based therapy. We study Parkinson’s (PD) and Huntington’s (HD) diseases, which are degenerative diseases of the brain.

Read more about NeuroStemcell

 

Italy meets the UK to discuss the future of stem cells in the clinic




Over 100 Italian and UK scientists and politicians came together on 12 December for a Summit on Regenerative Medicine organized by the Italian Embassy in London and the School of Science Technology and Health, University Campus Suffolk. Their aim: to bring the collective expertise of academics, industry and the political world to bear on the question of how to take basic stem cell research towards the clinic.

We went along to the meeting - read our report on the discussions



Inside the lab

We’ve got two new guest bloggers on our site: Anestis Tsakiridis is sharing his insider’s view of stem cell research in his blogs, Behind the Bench: A series about researchers and their rituals; and we’re delighted to welcome Alzheimer’s researcher Selina Wray, who posted her first blog, A fish out of water, on our site just last week.

Meet the stem cell scientists

We’ve also been busy talking to experts across the stem cell field. Read our interviews with Cedric Blanpain, Yann Barrandon, Christine Mummery, Doug Sipp, Karen English and Nick Barker on the site now and keep your eye out for our chats with Jane Visvader, Connie Eaves and others in the New Year.

Stem cell factsheets


We’ve got an ever-growing set of fact sheets giving quick access to the key facts about different areas of stem cell and regenerative medicine research. The content is written by researchers and  reviewed by senior scientists.  The fact sheets are designed for non-specialists but why not check them out next time for a quick overview next time someone asks you about something a little outside your own field? Take a look at the whole collection (13 published so far, some in French & German too), but here’s one of our latest…

Type 1 Diabetes: How could stem cells help?

Diabetes is a common life-long condition and the number of children being diagnosed with type 1 diabetes is increasing. The symptoms can be controlled but there is no cure. For many, diabetes means living with daily insulin injections and the possibility of long-term damage to their health. How might stem cells help?Read our factsheet about stem cells and diabetes


 

Keep up with Europe’s stem cell news

Sign up to our newsletter to stay in touch with all the latest news from the EuroStemCell project. From February 2012 we’ll be sending out a  monthly newsletter. For more regular updates, you can follow us on Twitter, check out our Facebook page or subscribe to our RSS feeds.  And if you haven’t visited the site for a while, do take a look and get in touch with your feedback and ideas.
GD Star Rating
loading…
Share

Category Discussion, Education, Highlights, Interview, News, Research | No Comments »

PHD Comics on the big screen

Posted by on November 17th, 2011

The web comic Piled Higher and Deeper (PHD) has been commiserating with graduate students since 1997. And now you can watch the comics come to live on the big screen, as universities and institutes across the world (including Antarctica!) are screening the PHD movie.

Fans of the comic will recognize most of the jokes, but now the individual 3-panel strips have been turned into a full-length movie with a plot that summarizes the main story of the long-running comic. The film was shot in its entirety at the Caltech campus last spring, and all actors are students and staff from Caltech. As they’re by and large professional scientists rather than professional actors, the acting isn’t always very sharp, but they did a great job at bringing the comics to life. The trailer below gives a good indication of the film.

PHD Movie Trailer from PHD Comics on Vimeo.



Most screenings are only open to students from the hosting institution, but I was lucky to hear about an open screening at University College London. Even though the screening was open to absolutely everyone, the lecture theatre was not entirely full. Perhaps it really does appeal specifically to grad students? Nevertheless, the people who did attend seemed to enjoy the film, and laughed at every joke. Even the ones that you could see coming from a mile away if you were familiar with the comics.



But this was not just any screening: it was one of the few that PHD Comics creator Jorge Cham was attending. After the film, science-loving comedian Robin Ince hosted a Q&A with Jorge and with Alex Lockwood - the actress (and graduate student!) who plays the character of Cecilia in the film. Alex initially kept her role in the film a secret from her advisor. “I didn’t tell him I was doing it for a while, but his wife is really nosy on Facebook…” Once he found out, he was a lot more excited about the film than she was – as long as she still got her work done, of course.

Despite being based largely on the existing comic strips, the end of the film breaks a longstanding tradition. In the fourteen years that Piled Higher and Deeper has been running, the main character was never named. In the film, he finally introduces himself. When this came up during the Q&A, Jorge explained why the student didn’t have a name to begin with: “First I was just kind of lazy, but then it became a funny thing. It took my own professor about four years until he learned my name.” But now, wanting to give the film a more interesting resolution, the student gets a name. “I figured it was about time. And I can always deny that it’s not comic-canon, that it’s just movie-canon…”

After the Q&A, we caught up with Jorge and asked him how the film translates to international audiences. It’s set in the US, where PhD degrees can regularly take 5-7 years, and many jokes are based on the fact that graduate school takes forever. My own favourite joke involves Cecilia’s encounter with a high school classmate:



But in the UK, where several universities have now screened the film, PhD degrees are much shorter than in North America. Do the jokes hold up?

“Well I heard that the guitarist from Queen took 35 years to finish his PhD, so I think he pulls up the average,” jokes Jorge, “But I think what translates the most is that feeling of uncertainty, feeling stuck and not being quite sure what you’re going to do next. That’s international.”

Regular readers of the Node may recall that we’ve interviewed Jorge before, and that he mentioned a “biologist character” that would appear in the comic very soon. What is happening with that, we wanted to know. “That’s still coming, but probably not for another year, at least.” Aww. But of course, this is the man who has turned procrastination into a career: Jorge left research several years ago to pursue the comic full time, and to give talks about procrastination to graduate students. To tie in with the various posts we’ve had on the Node about alternative careers, we asked him what he learned in his PhD degree that he still uses today.

“Many things. I think part of what I do as an artist is trying to discover where the truth is - or at least ask the question “where is the truth?” - and being able to think analytically in a big picture sense but also being able to drill down, and work on the minutiae of the details. I think the PhD gives you that kind of macro/micro vision at the same time. But mostly it just gives me the ability to avoid questions…”

If you’d like to see the movie yourself, here is a list of places that are showing it. And if you’re a bit more patient (now there’s something you learn in grad school!) you can wait for the DVD release, tentatively planned for Pi Day (March 14) next year.
GD Star Rating
loading…
Share

Tags , , ,
Category Interview, News, Video | No Comments »

An Interview With Ottoline Leyser

Posted by on October 25th, 2011

(This interview originally appeared in Development.)

The Sainsbury Laboratory at the University of Cambridge is a new research institute that aims to achieve an integrated understanding of plant development. Its Associate Director is the new plant Editor of Development, Ottoline Leyser, who is also Professor of Plant Development at the University of Cambridge. We recently caught up with Professor Leyser and asked her about the Sainsbury Laboratory and about her own research interests.

When did you first become interested in plant development?


To me, plant development has always been much more interesting than animal development, because of its plasticity. In plants, the body plan is incredibly flexible: one genotype can occupy an extraordinary range of phenotype space. I’ve always thought that was just amazing.


I did my undergraduate degree here in Cambridge, in the Genetics Department, not in plant science. We had this absolutely fantastic interdepartmental development course that was taught by John Gurdon, Peter Lawrence and many other wonderful people. It was very striking, the contrast between what was happening in animal development, which was being transformed by Drosophila genetics, by Christiane Nüsslein-Volhard, Eric Wieschaus and others, and what was happening in plants: despite the long tradition of genetics in plants, developmental genetics somehow hadn’t really taken off. But in the final year of my undergraduate degree, there were the first hints of Arabidopsis as a model organism, driven at least in part by Elliot Meyerowitz, who is now the inaugural director here at the Sainsbury Laboratory. So, there was suddenly a very exciting opportunity to push things ahead in plant development using developmental genetics. I started looking for a PhD position in an Arabidopsis lab and, fortunately for me, Ian Furner had just arrived back from the USA clutching some Arabidopsis seed in a tube, so I stayed in Cambridge and did my PhD with him, studying meristem mutants in Arabidopsis.


What are you working on at the moment?


I’m working on the role of plant hormones in integration of the endogenous and environmental signals that control the plant body plan. We’re looking principally at shoot branching control and are trying to understand how every individual axillary bud on the plant makes a decision about whether to activate or not, depending on multiple inputs. It’s really a question of signal integration.


You’ve recently moved your lab from York to Cambridge to set up the new Sainsbury Laboratory. How did the lab move go?


It’s still an ongoing process. We’re pioneers down here, who have had to deal with a very fabulous but nonetheless brand new and, at the time, unfinished building. But now that the first results from experiments carried out in the new lab are coming in it’s very exciting. Meanwhile, there’s still a core of people in York, partly because some people didn’t want to move and partly because we’re in the middle of a rather long-term ten-generation Arabidopsis experiment, which I didn’t want to move.



Read the rest of this entry »

GD Star Rating
loading…
Share

Tags , , ,
Category Interview | 1 Comment »

An Interview With Gordon Keller

Posted by on October 19th, 2011

(This interview originally appeared in Development.)

Gordon Keller is Director of the McEwen Centre for Regenerative Medicine at the University Health Network in Toronto, Canada. His research applies concepts from developmental biology to the investigation of the lineage-specific differentiation of mouse and human embryonic stem (ES) cells. He became an Editor of Development in 2011, and recently we asked him a few questions to find out more about him and his research.

Who or what inspired you to study science?

I was always curious, and I found a scientific career to be one that allowed me to explore my curiosity.

What sparked your interest to work on the directed differentiation of stem cells?

That was a seminar by Rolf Kemler in 1984. I was in the Basel Institute for Immunology – I had arrived there about a year earlier – and Rolf came to the institute and showed us these beautiful, huge cystic embryoid bodies, in which you could see blood and vascular structures and beating heart cells. Knowing that you could make that from an ES cell piqued my interest and I decided to pursue research in this topic.

What made you return to Canada after having worked in Switzerland and the USA?

There were several things. First, there was an opportunity here to direct the McEwen Centre for Regenerative Medicine. Canada, and Toronto in particular, has a very strong scientific community but also a very strong stem cell biology community. And I am Canadian, and felt it would be a wonderful opportunity to return home and spend part of my career here.

What has been the biggest surprise that you have come across in your research?

I don’t know whether you would call it a surprise, but I have been amazed at the speed at which stem cell research has progressed. We have worked for years at differentiating mouse ES cells, and, although people were interested, it was always somewhat on the back burner. Then the discovery of human ES cells and induced pluripotent stem (iPS) cells transformed the field, and the kind of work we do has now become more mainstream. In a nutshell, I don’t know if I have been surprised by any particular finding so much, but what I find most remarkable is the evolution of the field and seeing it change almost on a weekly basis.

Given these ongoing changes, where do you see the field move next?

I think the biggest challenge that we have is to find a way to get the cells that we make in a dish to integrate into adult tissue and function. We are certainly making components of human tissues and organs, but to date there is not much evidence yet that they are functional, so I think the next hurdle – the big challenge before we can really make an argument that these are clinically relevant cells – is to find out whether in vitro differentiated cells can integrate into adult organ function.

How does developmental biology inform in vitro differentiation?

Developmental biology is the basis of all we do. For the last eight years, we have looked closely at concepts from developmental biology; for example, the pathways that control lineage specification in the early embryo. We initially applied these concepts to mouse ES cells, and more recently to human ES cells. Using knowledge from developmental biology has provided us with a very informed way to develop strategies and protocols that are both robust and efficient.

What is the role of Development within your field?

Many of the key papers that we look at to inform our work have been published in Development, and we have published a lot of our own ES cell work in the journal as well. At times, publishing our work has been challenging, I must say, because when we started it was a new system and a lot of people didn’t believe that cells in a dish could recapitulate development. But Development was very supportive and allowed us an avenue to publish our research.

Is there a particular type of in vitro differentiation paper that you would encourage people to submit to Development?

Absolutely. I would like to see ES cell differentiation papers coming to Development. This could include papers that use the system to study aspects of development that are very difficult to study in an embryo, and there are many examples of that. As we are starting to move from animal models towards human biology, ES cell differentiation is going to be the model for human developmental biology, and I would be delighted if the journal could stake a claim to human developmental biology.

If you were not a scientist, what career would you have chosen?

I have no idea. In fact I’m not sure that I had a priority to start with. I didn’t grow up saying ‘I want to be a scientist’, but rather I followed a path where my thoughts were along the lines of ‘I find this interesting, I’ll pursue it somewhat more’.
GD Star Rating
loading…
Share

Tags , ,
Category Interview | No Comments »

Yukiko Yamashita, a developmental biologist at U-M, named one of this year’s MacArthur fellows

Posted by on October 13th, 2011

Photo credit: U-M Photo Services What would you do if you were given $500,000 to fund your research for five years, with no strings attached –– no proposals to write, no progress reports to submit? If you were one of the recently announced recipients of the prestigious MacArthur fellowship you would be giving this question some serious thought.

Every year since 1981 the John D. and Catherine T. MacArthur Foundation recognizes exceptionally creative individuals by awarding them with $500,000 “genius grants”. According to the press release published on September 20th “MacArthur fellowships come without stipulations or reporting requirements and offer fellows unprecedented freedom and opportunity to reflect, create, and explore. All [fellows] were selected for their creativity, originality, and potential to make important contributions in the future.”

To be considered for the MacArthur fellowship requires a nomination.  However the identities of the nominators as well as the selection process are kept in complete secrecy.  Those who are selected for the award find out through an “out of the blue” phone call from the foundation two weeks prior to the official announcement. This year’s 22 recipients include a musician, a poet, a historian, an economist, a radio producer as well as 10 scientists.  Among them is Yukiko Yamashita a developmental biologist and assistant research professor at the University of Michigan who studies the mechanisms regulating stem cell division in the context of unperturbed tissue anatomy –– adult testes.

Getting the Call

When Yukiko received the phone call informing her about being selected and asking her asking her not to discuss it with anyone except her spouse until the official announcement, she had a hard time believing that it was not a scam. “I called my husband right after I hung up my phone call with the foundation and [he] seriously warned me that ‘if you get a second phone call asking your bank account and pin number, so that they can transfer the award money, don’t give it to them.’”

They did not ask for her bank info but did want to bring a production crew to her lab to film an interview for the foundation’s website.  “I had to ask the director of my institute if the production crew can come into the building to film me before the press release. We seriously have to worry about some activists against research blowing up the building. I didn’t want to be the stupid assistant professor who believed they are awarded a MacArthur ended up with destroying the entire institute.” When the names of this years MacArthur fellows were finally announced publicly Yukiko felt more relieved than ecstatic.

Yukiko completed her undergraduate and doctoral studies in Japan, at Kyoto University, followed by postdoctoral training with Margaret Fuller in the Department of Developmental Biology at Stanford University. In 2007 she established her own lab as an assistant research professor at the University of Michigan Medical School.

Choose Your Centrosome Wisely

Her current research, which has won her the recognition from the MacArthur foundation, combines cell and developmental biology and is focused on investigating molecular and cellular mechanisms governing stem cell behavior, using the Drosophila male germline stem cells (GSCs) as a model. Her lab is investigating how stem cell division is regulated and how different stem cell populations interact to maintain tissue stability.

During her time at Stanford, Yukiko made the discovery that the centrosomes of Drosophila male GSCs are non-randomly segregated during asymmetric division –– the older “mother” centrosome remains with the stem cell while the newly replicated “daughter” centrosome is inherited by the differentiating cell.

The GSCs in Drosophila reside in a niche composed somatic support cells called hub cells and cyst stem cells. GSCs attach to the support cells at their apical side and during cell division orient the mitotic spindle along the apical-basal axis.  The cells still attached to the hub after cell division maintain a stem fate, while the daughter cell, displaced from the hub, differentiates.

“Its been known for quite a long time in the cell biology field that mother and daughter centrosomes are a little different from each other. The newborn centriole in the centrosome takes more than one cell cycle to get fully mature,” says Yukiko. As the centriole matures it accumulates structures called subdistal appendages, which serve to anchor the microtubles forming the spindle. Mature centrosomes therefore have a stronger ability to anchor microtubules. “Because of this difference the mother centrosome always has higher microtubule nucleating capacity.” In fact Yukiko’s found that the mother centrosome is anchored by microtubules at the apical pole of the cell, near the hub. “That is why, we are guessing, the mother centrosome can stay close to the hub cells all the time.”

However this mechanism is not universal to all stem cells.  “In Drosophila neuroblasts, every single cell cycle the mother centrosome gets inactivated and the daughter centromosme gets activated and so, unconventionally, the daughter centrosome has higher [microtubule organizing center] MTOC activity. In the end the stem cell ends up inheriting the daughter centrosome all the time.” The reasoning for this switching is not known, however the trend is that the centrosome with higher MTOC activity is inherited by the stem cell.  “In one case, germ line stem cells maintain higher MTOC activity on the mother centrosome, but in the Drosophila neuroblasts they make daughter centrosome with high MTOC activity. Why this is happening we don’t know. But once you have high MTOC activity it looks like that’s going to the stem cell.”

How Do Chromosomes Fit Into the Picture?

Following Yukiko’s discovery about the non-random segregation of centrosomes other scientists in the field speculated that it might serve as a mechanism to selectively segregate chromosomes, perhaps keeping the original strands in the stem cell as proposed by the immortal strand hypothesis. Yukiko, however, was not convinced that this was the case and thought that a thorough analysis was required to prove or disprove the hypothesis –– something that she felt was lacking in some studies.

“We thought we really should address this question in our system, in which we can directly test this idea,” she says.  In early 2011 Yukiko’s group published a paper in the Journal of Cell Science reporting that the chromosomes of GSCs, unlike the centrosomes, are randomly segregated.  “I’m glad that we published this paper because I think [among] the immortal strand hypothesis papers, some are really good and the data appears really convincing, but some others are not really excluding alternative possibilities or different interpretations. I really wanted to propose some rigorous way of testing it. I’m not saying that the immortal strand [hypothesis] is not correct, but then to make it right, you have to examine every single possibility.”

Since that publication, a the graduate student pursuing this line of research in her lab has examined the segregation of each individual strand for all the chromosomes and  found that at this level of resolution only a small subset of chromosomes are selectively segregated, while the segregation of others is random.  “It looks like germline stem cells are segregating very specific strands with quite high bias only for some of  the chromosomes, but not others, so that at least suggests that cells have the machinery to distinguish one chromosome strand over the other and then segregate one into the stem cell in a biased way.”

This finding that the majority of the chromosomes are randomly segregated still leaves the question of why cells need to selectively segregate their centrosomes?  “Ultimately the question everybody is asking is: does the mother or daughter centrosome carry some information, not just microtubules?”

Yukiko doesn’t yet have the answer but can speculate about the possibilities.  “The centrosome itself [could be] associated with some sort of fate determinants. That is not unprecedented. Some fate determining mRNA is associated with just one centrosome during mollusk early embryogenesis.  [Another possibility is that] the centrosomes are used to distinguish two different sister chromatids, to segregate one strand over the other.  Why you have to distinguish one strand over the other strand of the chromosome? I don’t think its for the sake of an immortal strand, I don’t think its because of the DNA mutations or avoiding them, instead I think it’s some epigenetic information that they want to carry. It might be histone modifications or DNA methylation but we don’t have any evidence for that yet.”

Checks and Balances

In addition to their work on centrosome segregation Yukiko’s group is pursuing two other lines of research.  One is examining a novel cell cycle checkpoint, which ensures the correct orientation of centrosomes prior to cell division. “We published one paper suggesting the presence of a new checkpoint that, in GSCs, makes sure the centrosomes are correctly oriented before they get into mitosis. If the centrosomes are not oriented correctly, this checkpoint gets activated and then stalls the cell cycle before entering mitosis. We really want to identify the mechanism of how stem cells are sensing the correct orientation of the centrosome before getting into mitosis.”

The idea of a cell-cycle checkpoint is more at home with cell biologists and Yukiko thinks that it will take some time to convince developmental biologists that what they are describing is a real phenomenon. “I think its going to be a long way to really prove that this really exists, exactly how cells are sensing it, and what is the molecular mechanism, etc. It will probably take multiple papers and probably quite long time; at least five years if not 10 years.”

Yukiko also wants to understand how different stem cell populations interact in tissues and communicate to coordinate their replication and life cycles.  This is a new line of research for the lab and Yukiko wants to explore this direction in the coming years.

“[The Drosophila male gonadal] stem cell niche contains yet another type of stem cell called cyst stem cell. The germline stem cells and cyst stem cells have to coordinate their divisions somehow, we don’t know exactly how yet. Many tissues are made of cell types that are coming from different stem cell lineages. That means the decision of one single stem cell population cannot be enough to maintain the whole tissue. One stem cell population has to coordinate with another stem cell population to make sure that tissues are maintained as a whole. I’m very, very interested in how the stem cells are coordinating with each other.”

Follow Your Passion

What does getting the MacArthur fellowship mean for the future directions in the lab? Most importantly in means freedom to pursue any interesting outcomes that arise in research without the constraints of sticking to a proposed research plan.  “The whole idea of being a scientist is that you can’t really predict anything. If you’re working on something and the answer is so predictable, its quite boring.  Now I feel I do have the freedom to wander off a little bit from the original plan, because of course I didn’t propose anything for the MacArthur!”

Having a passion for science it vital for success as a scientist, but it doesn’t mean that your whole life has to be about work. Yukiko admits that she used to get worried when life’s distractions took too much time away from the bench.  What helped her to establish a career as an independent researcher and develop a life-work balance was learning “laid-back confidence” from her postdoc mentor Margaret Fuller.  “She’s a really good scientist but she is not obsessed by success. You can love science, but it doesn’t have to be your whole life. Other things enter your life that may take time away from the science, but don’t worry.  It might take you a little longer, but you will get to the point where you want to go if you just continue what you’re doing. That is something I learned from her.”

Yukiko spends her free time with her family and taking care of her six-year old daughter. I asked Yukiko if there is something people would be surprised to learn about her. “I am really obsessed with fossil hunting,” she said.  In Michigan, which used to be under tropical water millions of years ago, finding fossilized coral can be as easy as examining the pebbles on the road for a few minutes.  “It’s becoming a fun hobby for my daughter and me.”  After some thought she added: “And another thing my husband always teases me about ‘Where is this assistant professor who sleeps 8-9 hours a day?’ It’s how much I sleep every day!”

For more information:

Profile of Yukiko Yamashita on the MacArthur Foundation website

Press release from the MacArthur Foundation announcing this year’s fellows

Yukiko Yamashita’s lab webpage

References

Yadlapalli Swathi, ChengJun, YamashitaYukiko M. (2011). Drosophila male germline stem cells do not asymmetrically segregate chromosome strands. Journal of Cell Science, 124, 933-9.

Yamashita Yukiko M. (2010). A tale of mother and daughter. Molecular biology of the cell, 21, 7-8.

Yamashita Yukiko M. (2009). The centrosome and asymmetric cell division. Prion, 3, 84-8.
GD Star Rating
loading…
Share

Tags , , , , ,
Category Interview, Research | No Comments »

A Discussion between Eric Wieschaus and Marcos González-Gaitán

Posted by on September 22nd, 2011

Eric Wieschaus is a Professor at Princeton University, USA. He was awarded the Nobel Prize in Physiology or Medicine in 1995, together with Christiane Nüsslein-Volhard and the late Edward B. Lewis, for their work “uncovering the genetic control of embryonic development”. Throughout his career, he has been interested in the mechanisms underlying patterning and morphogenesis in the early Drosophila embryo. You can find a short film featuring Eric, made at The EMBO Meeting here.


 Marcos González-Gaitán’s main interest lies in fly development as well. He started his lab at the MPI-CBG in Dresden, Germany, and in 2006, his group moved to the University of Geneva, Switzerland. Marcos has made major contributions to our understanding of how morphogen gradients are formed and regulate tissue growth. In his work, he combines cell biology and biophysics to address developmental problems in a quantitative manner.


 

I spoke to Eric and Marcos at The EMBO Meeting in Vienna last week. We talked about model systems, tackling details versus fundamentals, the future of developmental biology, and how to successfully collaborate with non-biologists. I hope you’ll enjoy reading about their experiences and thoughts!

What are currently the big scientific goals in your labs?

EW  I think I’ve always been interested in things that I can see. For me the focus is on morphological change - how cells change shape, how they move. I’m trying to do something slightly more biophysical, partially because I have this prejudice that physicists never have to remember much detail and you can get to an understanding without knowing all the details.

MG  What we are increasingly caring about is how tissues proliferate and grow, also taking a biophysical and cell biological approach. Of course I care about the details, but I try to see what can be fundamental beyond the details. I don’t know if it’s possible, because the details are contaminating the fundamentals to a large extent.

EW  Yes, and we’ve almost never done well when we don’t look at details.

MG  Exactly.

EW  I think this is actually a little frustrating about the time we’re living in, because overall in the field, we have this desire to go to a systems level, and yet at least for me how to do science is really grounded heavily in particulars. Describing something in a general, global way isn’t as helpful for me….

MG  I have very strong opinions about this, where I might be completely wrong in fact, but that’s how I think these days about this problem. We all speak about model systems, like Drosophila and I also work in fish, and with these you want to do something that can be general to other animals.

So, you start off thinking that the general description is at the level of genes. I don’t know what’s Eric’s opinion is on this, but over my career, I realised that that’s not really true – beyond saying that this gene is doing signalling, and this other one is a transcription factor. Beyond that it’s difficult to say that what Ubx does in Drosophila is the same as the homologous gene in another animal.

Then I became a cell biologist, because I thought these details might be general. I studied endosomes and endocytosis thinking that I’m going to find the principles of how endocytosis interfaces with signalling, and that’s going to be general. But, you also find out that that’s not the case, at least that’s my perception. The same endosome in the next system has totally different properties. It’s not general.

So then I moved into some biophysics and physics, thinking the universality is going to be in these physical properties, whatever they are - tension, mechanics or scaling of gradients. And now I’m getting to the point where this is probably also not true! Why is this? – I think its probably evolution; in every single system evolution has tinkered around with properties. So then where is our value?

My thinking today is that the real value is the approach. You ask questions to have solutions to these questions, and you develop tricks, assays - intelligent and elegant ways of thinking about the problem differently. In your little system, where the details are very important, you come up with a solution. I don’t think this solution is going to be universal. But the value, in my opinion, is that someone working in a different system can look at my study in flies or in fish and say, this is an interesting way of looking at the problem. You can measure degradation rates by doing FRAP, and then they can use these tricks or this way of thinking to apply to their system - the solution is probably going to be totally different.

EW  One thing that struck me was, you said that model systems are model systems because we think of them as leading to generalities. That is actually what the word means. The reality is that model systems, at least in the fields we work in, exist not because it has anything to do with generality, but because experiments were easy to do in them. We stupidly call them model systems, but we really work in them because I can go into the lab and have a chance of setting up an experiment in a way that leads to a conclusion that’s admittedly very specific. However, you’re not going to be able to do those experiments in anything other than the five or ten model organisms. So the real generality maybe is close to what you are saying, that the generality is that model systems allow the approach, allow us to pursue a scientific approach.

The curious thing, as biologists, we worry a little about generality, but one of the accusations the physicists make about biologists is that we don’t see the forest for the trees. We see trees all the time, it’s all we see, we see little specific trees. And my physicist friends worry a lot about whether what we’re doing is important, or generalisable? They always ask that question, and my reaction with time has become: Oh yes, it’s going to be generalisable, and somebody really smart some time down the road is going to see all of this, it’s all going to fit together in some picture - maybe! But right now I’m happy with trees, I’m happy that I can go into the lab and get something that is admittedly specific about flies, but at least is probably true, and measurable.

MG  The question is whether the problems we are addressing now, are comparable to trying to understand the double helix etc. We have the tendency to believe that it’s not, because we’re so much into our thing. But then, very often when people look back, they say, “These guys were doing absolutely fundamental research!”, but at the time they were just looking into this very particular thing. I ask this question all the time, are we looking at something fundamental or just the details. Because when I started to do developmental biology, I thought all my colleagues who did botany were completely boring, because they were just describing petals and sepals, while I was doing something fundamental. But with age, I’m not sure that I’m not just looking at petals and sepals, I’m not sure…

EW  Well you know, some day, somebody will know, but we will fortunately not be around!

In your view, what will be the future of developmental biology?

MG  I organise retreats in my lab, which often have this question - What is going to be the future in 5, 10 years. And it’s funny, my students and postdocs in the lab would say that the future is physics and to measure things. I think that’s not the future, that’s now! I have the feeling that we are neglecting some other things that might be the future, and that is chemistry. We think of proteins and genes, but there are all also lipids and sugars, and we are ignoring them completely! Maybe the future could be to measure them, find out where they are and how they influence things. Chemistry could be the future.

EW  Maybe the future is ignorance! Meaning where the future is, is where we’re ignorant today. So, in a way, asking where the future is, is to ask what are the things that we don’t know. That’s the question I never ask because if I would make a list of all the things I don’t know, I’d just spend all my time making that list. Beyond the idea that it’s just in the things we don’t know today, your job as a scientist is to find something you don’t know and figure it out.

MG  I think the future is determined by new ways of looking at things and then you can just ask different questions. For example, when I started my PhD with Garcia-Bellído, I was looking at work that he was proposing, and that Eric was proposing, which back then, meant to look at cells. At that time, developmental biology was not looking at cells at all - I’m talking 1985. So I thought the future is in cells, single cells, and it became the future in the 90s and 2000s. The same now with physics, people started to do this, so that can change the way we look at things and we will find things that we don’t know now. In this sense the new way of looking at it is maybe chemistry, but perhaps other things that my students may see one day, but not me.

EW  I suppose if you were an administrator at a university deciding where you’re going to throw money, clearly one of the places that you could decide to throw money is in re-vamping chemistry departments, which many places now do. And that might be another test of where the future is - it’s where the people who have money are throwing it!

So they might set the future by throwing money there, because money usually makes things possible?

EW  Yes, and when things become possible, unless people are cruelly incompetent, something good comes out of… going to the moon.

How did you start your collaborations with physicists, and do you have advice for others who are trying to do this?

EW  I’m totally dependent on proximity. I don’t like talking on the phone, I type badly, I don’t write - I have to have people who are next to me, and I have to get along personally with them. What helps me a lot is that I’m at a university that has a very strong commitment to undergraduate teaching. It’s a great university with a lot of very smart people, but we all teach undergraduates, and we all often teach together. And so a lot of my contacts with physicists or with computer scientists are through my teaching. It’s odd, because you think, “God if I didn’t have to do so much teaching I could be really, really good and accomplish all kinds of stuff!”, but for me, teaching has been a very important part of my scientific development over the past 30 years. It’s brought me into contact with colleagues and people that I wouldn’t necessarily have found common ground with.

MG  First, I think that very often biologists, when they go into these quantitative things have an agenda. They want to be proved right, and then they use these guys to prove them right. That is a short-term agenda. I think doesn’t work. In my case, I probably started in this way, but my main collaborator, Frank Jülicher, he’s a very deep person, and we have had to take our time to understand each other. Fortunately, we never had time pressure - we saw a problem and stepped back to the fundamentals. And we went slowly. It takes time; to me not rushing is something important. Second, I’m discovering that there is a component of personal chemistry and respect that is very important. The physicist needs to respect, appreciate and value, and want to understand the experiment and the details of it. And you need to do the same with their science; you need to understand how they solve the differential equations at some point because there is value in that.

What career advice do you give to your students and postdocs?

EW  Work hard! Really, work hard, and be successful. Meaning that make choices always based on “Is this going to be successful?”, and be able to make that judgement. Be able to change, be flexible. You have to work really hard; you have to work on the weekends and all these things. But it’s not an excuse after a year or two to say, “Well, I worked really hard, somebody should hire me.” They’re not going to hire you because you work really hard; they’re going to hire you because you’ve actually accomplished something. And it’s impossible to accomplish something unless you work hard, and you have to finish stuff. You have to bring things to conclusions.

MG  I’m more of a dreamer, I’m not so pragmatic. What I tell them is, value your career of course, but be beyond that, you want to understand something, and that is the uncompromisable thing. Do what is important to you, do work hard indeed, but go for a problem, understand something. I think that is the fuel to work hard and to improve your career. It allows you to relax a little bit about this pressure that everybody is feeling now, about crises, problems; you just focus on your problem. If you cannot do this, it does not work.

EW  Yes, it’s really hard to work hard if you’re not passionate. It is the passion I guess that allows you to believe that if you work hard, you’ll accomplish something.
GD Star Rating
loading…
Share

Tags , , , , , ,
Category Events, Interview, Research | No Comments »

An Interview with Janet Rossant

Posted by on September 13th, 2011

I arranged to talk to Professor Janet Rossant after her talk at The EMBO Meeting here in Vienna. Janet is Chief of Research at The Hospital for Sick Children in Toronto, besides being a University Professor at the University of Toronto. Throughout her career she has been and still is making major contributions to the understanding of early development of the mouse embryo.

During the interview I took the opportunity to ask her about her career, her thoughts on the future of developmental biology and for some advice for young scientists. I hope you enjoy reading it as much as I did talking to Janet!

Why did you become a developmental biologist?

When I was an undergraduate many years ago in Oxford, I was taught by John Gurdon. John Gurdon is one of the world’s famous developmental biologists, still active and he did all the early work on Xenopus embryos, nuclear transfer embryos. He really got me excited about this idea of how it is that a single cell develops into a whole organism, and how you can begin to manipulate embryos, understand particularly the early stages. So I found that really exciting.

After I finished my undergraduate degree I thought I’d do research. So I talked to John, who suggested that I might talk to Chris Graham, who had started to do the same things in mouse embryos. Chris sent me to Richard Gardner, who was starting to make mouse chimeras, and I switched into mouse. I’m still interested in the fundamental question how the embryo develops, using the mouse system. And I must say that in the time - I switched to the mouse system in the late 70s, because I thought the Xenopus system was passé! Well, I was right about the mouse being an important system, but I was wrong about Xenopus, I apologise. I’ve stuck with the mouse ever since. Occasionally we’ve played a little with fish and various other organisms, and now of course we’re doing some stuff with human embryonic stem cells. Really that’s a direction we’re moving into, taking mouse development and trying to understand human development.

You’ve been involved in the public debate on the ethics of stem cell research and studying human development in Canada. What role did you have there and did you enjoy doing it?

Well, yes and no. There have been some very educational parts of that. As the human stem cell debate started to rage it became very clear to me that as developmental biologists and stem cell biologists we had to get involved. You can’t sit back and let the right wing politicians and lobby groups try to succeed.

I got involved through the CIHR, the funding agency for health research. They set up a panel to look at guidelines for human embryonic stem cell research, and I chaired that. So that would have been my first entree. With that we also had to appear before parliament and parliamentary committees. I’ve done quite a lot of public lectures in this area, to try to put forward the science, without necessarily getting into the ethical debate. At the end of the day, when people believe that a human embryo from the time of conception is worthy of all protection, you cannot argue against that. All I can argue is that we are in a situation where human embryos through IVF programmes are discarded, and isn’t it more ethically acceptable to use those discarded embryos to help save human lives in the future? I think that’s, the overall societal consensus pretty well worldwide and most people actually believe that that’s a doable thing.

You do have to educate people, and of course there are extreme groups who will not change their mind, but society can’t respond to extreme groups. Society as a whole has to come up with a consensus and we need public debate, and we need forums in which to do that. So I think it’s very important for scientists to get involved. Nowadays the CIHR guidelines exist, we have a regulatory environment, and human embryonic stem cell research is certainly proceeding in Canada. We also can undertake some forms of human embryo research, again with all the right conditions and approvals, unlike the States, where with federal funding you can work with existing cells, but you cannot use embryos or make new cells. In Canada we can, if approved, so it is a big advantage.

You’re British, but you ended up in Canada. Why, and have you ever considered coming back?

It’s simple, I married a Canadian. But it’s turned out to be very good; I’m still married to him, and I really enjoy having a career in Canada, it’s been great. I certainly looked occasionally and I obviously have a lot of colleagues and family still in the UK, associations I’d like to keep up. I don’t think at this stage I’m likely to move back in any major scientific role, but never say never, we’ll see!

What were the most exciting moments during your career?

First of all, we were very early involved in doing knockout mice. Oliver Smithies and Mario Capecchi had just shown that homologous recombination was possible in ES cells. My colleague Alex Joyner and myself knew that if we wanted to study genetics in the mouse, we needed to be able to knock out genes. So we got really excited, and she and I together worked on making our first knock out. Getting the first PCR to see that we had actually knocked out the gene was very exciting. It was Engrailed-2, a homeobox gene that Alex had worked on. In retrospect, we were lucky because the frequency we got was quite high - Alex had a postdoc working for months after that to knock out Engrailed-1, who could not do that at all! It turned out to be because there were some genetic variations between the clones, so eventually it worked. So we were very lucky. At the time it was so exciting, you could give a seminar and say you’ve managed to make a knock out and they’d be falling out the door and try to find out how you did it.

The other one was whole-mount in situ hybridisation in embryos. Today everyone knows all the beautiful pictures, we can do movies, we can do everything. But being able to actually see patterns of gene expression in embryos, as opposed to even sectioned materials, where it’s hard to reconstruct the complexity of the embryo, was fascinating. People had done whole-mount in situs in Drosophila, but in the mammalian system, we were having a lot of trouble. One of my postdocs worked very hard to get whole-mount in situs working in the mouse embryo - everybody does it with Brachyury first because it’s so easy to see, but we cranked it up to see other genes.

I remember Siew-Lan Ang, who was working at the time on looking for novel orthologues of Drosophila genes. She cloned Otx2, an orthologue of Orthodenticle, involved in anterior function in the fly. She took me to the microscope one day, and said, “What do you think of that?” I looked down the microscope and there was a late gastrula, early neural fold embryo in the mouse where you can’t really see anything, it all looks the same and there it was, front to end Otx2 positive, a strict boundary, nothing behind, amazing. Those kinds of things, they really grab you.

What advice do you give to your students and postdocs today?

First of all, you have to follow your passion, because at the end of the day you have to be grabbed by a question and by your research if you really want to drive it through. If the passion isn’t there, then you’re probably not in the right game.

Secondly, I think today life is complicated, and there are so many opportunities. So I really encourage people to think about the different kinds of tools that one can apply to a question. Try to combine, as we’ve heard it in these talks today, precision of looking at a question, or a stage, or a process with some of the tools of systems biology to try to get out an integrated model. I think that to me is the biggest challenge, whether it’s in the embryo, in stem cells or anywhere else. You don’t even always have to do the data yourself, there’s a lot of in silico data out there that you can capture.

Where do you think developmental biology as a field is heading?

It’s a mature field, interestingly. You see that at meetings. We certainly don’t have all the details, but we do have a good fundamental understanding of how to put a fly embryo together, a mouse embryo, a frog embryo. We do know the main players, and when I look back, we didn’t! Hox genes were cloned; nobody knew they were going to be conserved across evolution, and nobody believed they were really doing the same things if they were conserved. It’s hard to put your brain back at that time. Conservation of function across development has opened up our ability to look at the systems, and the similarities and the differences have really been worked out.

So I think that we are getting into the details of developmental pathways. It’s going to go in the systems approach, it’s going to go down into the cell biology - how cells are behaving in embryos. The area we’ve been trying to move into is to use it perhaps more directly in a translational sense. To me, the exciting things around embryonic stem cells and iPS cells is trying to combine developmental biology to drive embryonic stem cells to look at human development and model disease. And I really start to think can we use that for new drugs and new therapies.

So, developmental biology, as ever, sits in a very interesting convergence area, where you can move into many different directions. My personal direction is two-fold: Get into the details of that blastocyst, and the other is to move towards human development and disease.

But developmental biology still is fundamentally interesting. The other thing that people do, and I don’t really recommend my people to do it, is of course Evo-Devo - it’s fascinating, but it cannot easily get funded. Unless you’re a Howard Hughes investigator, it’s very hard. If that’s what people care about and want to do, that’s fine. I think it’s very important and exciting, but in the broadest sense it’s hard if you want to get forward, since it’s hard to get funded.

What were the biggest challenges you had to face during your career, and how did you deal with them?

When I started in Canada in 1977, there were not many jobs anywhere at the time, since a lot of the universities in the UK, US and in Canada had done a big expansion in the 1960s, so all those professors were sitting in their positions. I ended up at a small university, Brock University, teaching biology and doing research. So the biggest challenge I had was to go from Oxford and Cambridge to a small university in a country I didn’t know, trying to make contacts and all the rest of it.

The way I took on that challenge was to stick at it and to network, network, network! So I went out from Brock and I found people to collaborate with. I did a lot of collaborations with Verne Chapman in Buffalo and I collaborated with people in Toronto, so that’s how I ended up in Toronto. You can’t sit and feel sorry for yourself, you have to go out and do something about it. In those days I had to actually get in the car and drive around, these days you’d probably skype with people all over the world and stay in your lab. But actually, I think it can’t work exclusively that way, you still need that personal contact.

If you weren’t a scientist, what would you like to do?

I don’t ask myself that so much anymore, because I’m getting to the end of my career. So if I’d lost all my grants now I could just stop doing anything. But in the middle of your career, when things are looking rough, you ask yourself, “What would I do?” - I honestly don’t know. I certainly enjoyed teaching when I was at Brock; this is again a piece of advice to researchers, do some teaching! It’s awfully good practice for learning how to give talks and communication, because it’s all about communication.

However, I did get a bit tired of teaching first-year biology and sit on the exams and all that. So I’m not sure I’d have the patience to do that forever. I like to cook, but starting a restaurant - forget that! Maybe I could have a small catering company. I also do quite a lot of administration, since I run a big research institute, so I always got involved in science policy and science administration. So I guess fallback, that’s what I would end up doing. But at the end of the day, although I actually enjoy that, I can’t leave the research behind, it has to be part of the equation.

What would we be surprised to know about you?

That I like watching Top Gear!
GD Star Rating
loading…
Share

Tags , , ,
Category Events, Interview | No Comments »

An interview with Magdalena Götz

Posted by on August 1st, 2011

(This interview originally appeared in Development.)

Magdalena Götz is the Director of the Institute for Stem Cell Research at the Helmholtz Center and Professor at the Ludwig-Maximilians-University in Munich, Germany. Her developmental work in neurogenesis has identified radial glial cells as the source of neurons in the developing brain. Magdalena joined Development as Editor in 2010, and she agreed to be interviewed about her scientific inspirations and about finding a place for adult stem and progenitor cells within developmental biology.

When did you first become interested in science?

I have always loved biology, and in school I was truly inspired by my biology teacher. In our rather non-innovative school system, we had a young American biology teacher who made us actually think and do things, and I was simply fascinated.

What was your PhD about and how did it inform your subsequent career choices?

My PhD was on development of the cerebral cortex and investigated how specific cell types develop and form their specific connections. This work laid the basis for many research questions, which I continued to pursue into much later stages. For example, it led to the isolation of specific progenitor subtypes in order to understand stem cell and progenitor heterogeneity, and the molecular specification of these subtypes. The new questions that arose from my PhD project also determined how I chose my postdoc lab, and many of the basic questions from this time still keep us busy now.

Did you have a mentor or someone who inspired you in your early career?

After my inspiring biology teacher in school, my PhD supervisor, Jürgen Bolz, was also key in shaping my way. His readiness to discuss science at any time was certainly very important to further fuel my enthusiasm for understanding how the cerebral cortex develops. My interest in developmental biology was originally inspired by a course at the Max-Planck Institute for Developmental Biology in Tübingen and by the fascinating questions of axon growth and regeneration studied by Friedrich Bonhoeffer and Claudia Stürmer.

Typically, I have always been inspired by people we call `Querdenker’ in German – i.e. people whose thoughts and ideas are contrary to common beliefs and who follow their own ideas entirely independent of the field. Therefore, people like Nils Birbaumer in Tübingen and Rüdiger Wehner in Zürich were important for me to see that following your own way and ideas is the way to go.

Read the rest of this entry »
GD Star Rating
loading…
Share

Tags , ,
Category Interview | No Comments »


Copyright 2010 - 2012 The Company of Biologists Ltd

Company of Biologists